BOLD vs MAS · P/E 0.1, $24.6M cap vs P/E 18, rev $7.83B
Boundless Bio, Inc. Common Stock (BOLD) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the BOLD and MAS stock pages for the full models.
Not investment advice.